Kaemmerer et al. evaluated 34 small cell lung cancer samples by immunohistochemistry, and, in their study, CXCR4 predominantly localized at the plasma membrane of the tumour cells, which was correlated with clinical data and overall patient survival [50]. The gene discussed is CXCR4; the disease is small cell lung carcinoma.